About Microban
Microban is a Healthcare company based in Huntersville (United States) founded in 1994, and was acquired by WMBarr in December 2011. Antimicrobial and odor-control technologies are developed for multiple industries. Microban has raised $64.65 million across 2 funding rounds from investors including Credit Suisse, TA Associates and WMBarr. Its website microban.com draws about 49 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 1994 and headquartered in Huntersville, United States, antimicrobial technology and odor control solutions are supplied by Microban to sectors including sportswear, textiles, and consumer durables. Operations function in a collaborative capacity, with surface modification and anti-microbial protections tailored to client needs and industry-specific regulations. Proprietary offerings encompass SilverShield for silver-ion treatments, ZPTech utilizing zinc pyrithione, and MicroGuard alongside MicroClean for broad protection.
- Total Equity Funding$64.65M (USD)
in 2 rounds
- Latest Funding Round$41.65M (USD), Private Equity Round
Feb 2005
- InvestorsCredit Suisse
& 2 more
- Acquired byWMBarr
(Dec 2011)
Funding Insights of Microban
Microban has successfully raised a total of $64.65M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $41.65 million completed in February 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $64.65M
- Total Rounds 2
- Last Round Private Equity Round — $41.65M
- First Round $23M
(Dec 1999)
- Investors Count 2
All 2 funding rounds of Microban with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2005 | $41.65M | Private Equity Round | – | – | |
| Dec 1999 | $23M | Series A | – | – |
3 investors in total: 3 institutional.
Investors in Microban
Microban has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, TA Associates and WMBarr.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are invested in by private equity firm TA. | ta.com | Boston, United States | ||
Wealth management, asset management, and investment banking services are offered. | 1856 | credit-suisse.com | Zurich, Switzerland | |
Manufactures cleaning and moisture control products for home maintenance. | 1946 | wmbarr.com | Memphis, United States |
Investor details for Microban
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Microban
35 people are tracked at Microban (14 in leadership, 21 in team).
| Name | Role | Group |
|---|---|---|
Glenner Richards | Director, Microbiology And Analytical Chemistry | Leadership |
Giorgio Rimini | Head Of EMEA Business | Leadership |
Bud Murray | Director Of Textiles & Aftercare | Leadership |
Matt Scott | Director Of Business Development | Leadership |
Ali Beirami | CEO | Leadership |
Souvik Nandi | Vice President, Technology And Innovations | Leadership |
Rob Tidwell | Vice President Finance | Leadership |
Patrick Leung | Operations & Sales Director | Leadership |
Brian Aylward | Director, Global Textiles Business | Leadership |
Rich Kenney | Director, Business Development | Leadership |
Brian Owen | Vice President Of Global Supply Chain At Microban International | Leadership |
Demetra Bernard | Director, Marketing | Leadership |
Dogan Reuter | Business Development Director | Leadership |
Steve Chaffin | Director Of Business Development | Leadership |
Bobiline Clark | Global Production Manager | Team |
Amanda July | Customer Service Manager | Team |
Daniel Bates | Senior Research Chemist - Innovations | Team |
Kimberley Cherrington 金伯利 | Senior Manager, Global Brand & Marketing Communications | Team |
J-Robert Beauchemin | Canada Sales Manager | Team |
Lisa Buffington | Manager, Financial Planning And Analysis | Team |
15 more people are available in the full profile.
Complete people profiles for Microban
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Microban
4 dated milestones of Microban across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Microban is founded.
- Funding First funding round of $23.0M.
- Funding Latest funding round, Private Equity Round, of $41.6M.
- Exit Acquired by WMBarr.
Competitors of Microban
Microban has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. |
Detailed competitors of Microban
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Microban
The website of Microban (microban.com) receives about 48.8K visits a month.
- Monthly visits48.8K
▲ 138.7% vs previous month
Websites whose visitors overlap most with Microban. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| agion-tech.com | 100% | View details | |||
| goulston.com | 88% | 4.7K | #3,988,597 | View details | |
consos.com | consos.com | 80% | – | ||
| ultra-fresh.com | 78% | #1,234,092 | View details | ||
bergeninternational.com | bergeninternational.com | 77% | #13,249,276 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 25 similar websites and full traffic analytics for Microban
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 25 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Microban (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Microban
Complete news archive for Microban
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Microban
Microban was founded in 1994 and raised its 1st funding round 5 years after it was founded.
Microban is headquartered in Huntersville, United States. It is registered at Huntersville, North Carolina, United States.
Microban is a funded company, having raised a total of $64.65M across 2 funding rounds to date. The company's 1st funding round was a Series A of $23M, raised on Dec 1999.
Founded in 1994 and headquartered in Huntersville, United States, antimicrobial technology and odor control solutions are supplied by Microban to sectors including sportswear, textiles, and consumer durables. Operations function in a collaborative capacity, with surface modification and anti-microbial protections tailored to client needs and industry-specific regulations. Proprietary offerings encompass SilverShield for silver-ion treatments, ZPTech utilizing zinc pyrithione, and MicroGuard alongside MicroClean for broad protection.
Microban's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Microban has 3 investors. Key investors include Credit Suisse, TA Associates, and WMBarr.
Yes. Microban was acquired by WMBarr in December 2011.